A California jury has awarded Christine Scott $5 million against C.R. Bard over injuries caused by the Avaulta Plus transvaginal mesh.
Scott filed a lawsuit against 2009 after the implantation of the Avaulta transvaginal mesh left her in chronic pain, entirely incontinent, and unable to have sex with her husband. The lawsuit said that doctors implanted two Avaulta Plus mesh devices, and that since that time, she has had to undergo eight surgeries and nine procedures to try to correct the damage.
C.R. Bard says it intends to appeal the Scott award, and their attorney said that the company maintains that Avaulta can be used “safely and effectively when used properly and when used with the right patient.”
The court’s decision could have far ranging implications as many lawsuits have been filed against Bard over their transvaginal mesh, of which 21 have been consolidated under U.S. District Judge Joseph Goodwin in a West Virginia federal court.
C.R. Bard no longer sells the Avaulta Plus in the United States; however it remains on the market in other countries, while Johnson & Johnson pulled its transvaginal mesh products from the worldwide market.